Trial reportMedicine2025
Dexmedetomidine versus ketamine for preemptive caudal analgesia in single-level lumbar laminectomy: A randomized controlled trial.
Trial report in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPostoperative pain following spine surgeries remains a persistent challenge for patients, surgeons, and healthcare facilities. A wide range of medications, including ketamine and dexmedetomidine, are used for analgesia in lumbosacral spine surgeries. This study compares the efficacy, hemodynamic effects, and side effects of adding dexmedetomidine versus ketamine as adjuvants to 0.25% bupivacaine for postoperative analgesia following lumbar laminectomy.
methodsThis prospective, randomized, double-blinded study was conducted on 60 adult patients scheduled for elective discectomy/laminectomy of the lumbosacral spine. Patients were categorized into 2 groups: the dexmedetomidine group (1 µg/kg with 20 mL of 0.25% bupivacaine) and the ketamine group (0.5 mg/kg with 20 mL of 0.25% bupivacaine). The primary outcome was postoperative analgesia assessment using the visual analog scale. Secondary outcomes included intraoperative analgesia assessment by monitoring end-tidal sevoflurane levels, hemodynamic parameters, and fentanyl requirements. Postoperative hemodynamic parameters and time to rescue analgesia were also evaluated.
resultsThe study demonstrated that dexmedetomidine provided more prolonged analgesia and better immediate postoperative pain control compared to ketamine. This was evidenced by a significantly longer time to rescue analgesia and lower visual analog scale scores in the dexmedetomidine group. Hemodynamic stability was better in the dexmedetomidine group, as evidenced by significantly lower and more stable intraoperative and postoperative heart rate and blood pressure values.
conclusionDexmedetomidine provides superior postoperative analgesia and pain control in the immediate postoperative period compared to ketamine. However, both drugs showed comparable efficacy at later postoperative times, indicating ketamine remains an option for pain management in certain circumstances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.